We Are Known For Our

CREDIBILITYVERSATILITYEXPERTISECAPABILITYINTEGRITYRESPECTTRUSTRELATIONSHIPSCOLLABORATIONREPUTATIONINSIGHTSKNOWLEDGEHONESTY
SERVICES
GET IN TOUCH

MORSE Services

lightbulb-idea

STRATEGIC ADVICE

MORSE Consulting offers ongoing strategic advice to optimize the prospect of reimbursement success throughout the Canadian pharmaceutical lifecycle.
Image Not Found On Media Library

ANALYSES

MORSE Consulting develops tailored reimbursement assessments and analyses to meet a client’s evolving needs – from comprehensive reimbursement landscape assessments to detailed time-to-listing analyses.
teamwork-in-the-office

ADVISORY BOARDS

MORSE Consulting organizes, facilitates, and participates in numerous types of advisory boards. This includes negotiation simulation sessions which help clients gauge payer reaction to a range of proposals.
presentation-board-with-graph

TRAINING

MORSE Consulting delivers training sessions on the Canadian pharmaceutical reimbursement environment that can be customized for various target audiences.

MORSE Reports

NEW Canadian Reimbursement Trends and Timelines Report Released!

Industry Feedback...

“The market access timelines within Canada are a broad and important issue and therefore, there is significant value in providing this information to companies on a regular basis. Global head offices frequently have questions regarding the Canadian reimbursement processes particularly after HTA recommendation. This slide deck would be a valuable tool for market access groups and business units to answer these questions and set internal expectations.”

– General Manager
Ontario-based Pharmaceutical Company

 “In our world of market access we know the processes inside and out, but where the advantage of this MORSE report lies for individuals like myself is in painting the picture of the public reimbursement process and timelines with our internal commercial teams, senior management and global voices as we determine launch plans for products in Canada.”

– Public Affairs Lead
Ontario-based Pharmaceutical Company

“This report is a useful tool to sensitize stakeholders, in particular MORSE’s expertise will allow us to answer internal questions regarding pCPA negotiations and timing of the letter of intent.” 

– Market Access Director
Quebec-based Pharmaceutical Company

“When working with stakeholders, such as patient groups, the timeline content of the report would be useful in order to map out strategy and timing. Ultimately, it would facilitate coordination across many silos, including internally within the Canadian team, the global team and with external stakeholders such as patient groups and payers.”

– Director of Market Access & Government Affairs
Ontario-based Pharmaceutical Company

MORSE Signals

Timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

The workload at pCPA appears to have stabilized over 2019

November 14, 2019
-
Market Access News

pan-Canadian Pharmaceutical Alliance (pCPA): October 2019 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the October 31, 2019 status of brand negotiations.  Highlights since the … Read More →

Read More →
MORSE
Posted by MORSE
3 MIN READ

Update on the CanREValue Collaboration

November 12, 2019
-
Market Access News

Development of a framework for the generation and use of Real-World Evidence for cancer drug funding.   The CanREValue Collaboration hosted a webinar on November 6, 2019 to … Read More →

Read More →
MORSE
Posted by MORSE
4 MIN READ

Average Time Under pCPA Consideration Below 30 Days for the 3rd Consecutive Month

October 16, 2019
-
Market Access News

pan-Canadian Pharmaceutical Alliance (pCPA): September 2019 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the September 30, 2019 status of brand negotiations.  Highlights since the … Read More →

Read More →
MORSE
Posted by MORSE
3 MIN READ

MORSE Key

Pharmaceutical Market Access Events Calendar

No event found!
Load More
MORSE Consulting Inc. - Deciphering Pharmaceutical Market Access
css.php